CSL Limited: Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³ finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Half year reported NPATA US$2 billion, Up 13% at constant currency singaporestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from singaporestar.com Daily Mail and Mail on Sunday newspapers.
Strong CSL Behring portfolio growth especially Ig
FINANCIAL HIGHLIGHTS4
Revenue $8.05 billion, up 11% at CC3NPAT $1.90 billion1, up 17%NPAT $1.94 billion1 at CC3, up 20%NPATA $2.02 billion1,2 , up.
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.